Abstract
Photodynamic therapy (PDT) utilizes the combined action of photosensitizer, light, and molecular oxygen to generate reactive singlet oxygen (1O2) to treat various diseases. Photosensitizer is a key component in PDT and its singlet oxygen quantum yield determines the effectiveness of its photodynamic reaction. This study evaluated the singlet oxygen production of a novel water soluble chlorin photosensitizer (YLG-I) using a 1O2-specificfluorescence probe - Singlet Oxygen Sensor Green reagent (SOSG). The spectra and singlet oxygen luminescence in different solvents were evaluated using mTHPC as a reference. It was estimated and verified that the singlet oxygen quantum yield of the new photosensitizer YLG-I was at the same level of the potent chlorin sensitizer mTHPC. Preliminary evaluation suggested that YLG-I was a promising photosensitizer for PDT.
© 2019 SPIE/OSA
PDF ArticleMore Like This
Jian Zou, Qiuyan Huang, Weijun Li, Shulin Zou, Zhen Han, and Zheng Huang
104170E European Conference on Biomedical Optics (ECBO) 2017
V.V. Klimenko, S.V. Shmakov, N.E. Kaydanov, S.V. Koniakhin, N.A. Knyazev, N.V. Kazakov, A.A. Rusanov, A.A. Bogdanov, and M.V. Dubina
1041703 European Conference on Biomedical Optics (ECBO) 2017
Sajid Farooq and Renato E. de Araujo
CL_P_4 The European Conference on Lasers and Electro-Optics (CLEO/Europe) 2017